"The team at Tri-Cities Gastroenterology -- serving the Kingsport, Johnson City, and Elizabethton, Tennessee regions -- shares a core belief: Every person who walks through their door deserves to be treated like family. They embrace every human and technological advantage possible to provide physical and emotional comfort to their patients. Their mission is to ensure that each person has the digestive health and wellness needed to live every day to the fullest. They work with you so you can truly enjoy life unencumbered by the distressing symptoms and potential limitations associated with gastrointestinal problems."

During the past decade, Tri-Cities Gastroenterology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tri-Cities Gastroenterology" #1 sponsor was "Pfizer" with 2 trials, followed by "Arena Pharmaceuticals" with 1 trials sponsored, "Capso Vision, Inc." with 1 trials sponsored, "Exact Sciences Corporation" with 1 trials sponsored and "Freenome Holdings Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tri-Cities Gastroenterology" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tri-Cities Gastroenterology" are "Colorectal Cancer" (3 trials), "Adenoma" (1 trials), "Colon Cancer" (1 trials), "Colon Diseases" (1 trials) and "Colon Lesion" (1 trials). Many other conditions were trialed in "Tri-Cities Gastroenterology" in a lesser frequency.

Most popular intervention types in "Tri-Cities Gastroenterology" are "Drug" (3 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrasimod" (3 trials), "Placebo" (3 trials), "Blood Sample Collection" (1 trials), "Capsule Endoscope" (1 trials) and "Freenome test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tri-Cities Gastroenterology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Tri-Cities Gastroenterology". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tri-Cities Gastroenterology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tri-Cities Gastroenterology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".